SWOG clinical trial number
SWOG-8700
Consolidation Therapy with High-Dose Cyclophosphamide and Total Body Irradiation, Followed by Autologous Marrow Infusion in Metastatic Breast Cancer, Phase II
Closed
Phase
Abbreviated Title
Consolidation Therapy with High-Dose Cyclophosphamide and Total Body Irradiation, Followed by Autologous Marrow Infusion in Metastatic Breast Cancer, Phase II
Activated
04/01/1988
Closed
01/01/1989
Research committees
Breast Cancer
Other Clinical Trials
SWOG Clinical Trial Number
S2206
A Randomized trial of neoadjuvant durvalumab plus chemotherapy versus chemotherapy alone for Adults with MammaPrint Ultrahigh (MP2) hormone receptor (HR) positive /Human Epidermal Growth Factor receptor (HER2) negative stage II-III breast cancer
Research Committee(s)
Breast Cancer
Symptom Control and Quality of Life
Activated
10/30/2023
Accrual
3%
Open
Phase
SWOG Clinical Trial Number
S2212
TIL Adapted Neo adjuvant Chemotherapy Optimization in Triple negative breast cancer (SCARLET)
Research Committee(s)
Breast Cancer
Activated
07/21/2023
Accrual
8%
Open
Phase
SWOG Clinical Trial Number
CTSU/NRG-BR007
A Phase III Clinical Trial Evaluating De-escalation of Breast Radiation for Conservative Treatment of Stage I, Hormone Sensitive, HER2-Negative, Treatment of Stage I, Hormone Sensitive, HER2-Negative, Oncotype Recurrence Score </= 18 Breast Cancer
Research Committee(s)
Breast Cancer
Activated
06/07/2021
Open
Phase